Literature DB >> 19855907

Comparison of I-FISH and G-banding for the detection of chromosomal abnormalities during the evolution of myelodysplastic syndrome.

R F Pinheiro1, M L L F Chauffaille.   

Abstract

Myelodysplastic syndrome (MDS) patients with a normal karyotype constitute a heterogeneous group from a biological standpoint and their outcome is often unpredictable. Interphase fluorescence in situ hybridization (I-FISH) studies could increase the rate of detection of abnormalities, but previous reports in the literature have been contradictory. We performed I-FISH and conventional karyotyping (G-banding) on 50 MDS patients at diagnosis, after 6 and 12 months or at any time if a transformation to acute myeloid leukemia (AML) was detected. Applying a probe-panel targeting the centromere of chromosomes 7 and 8, 5q31, 5p15.2 and 7q31, we observed one case with 5q deletion not identified by G-banding. I-FISH at 6 and 12 months confirmed the karyotype results. Eight cases transformed to AML during follow-up, but no hidden clone was detected by I-FISH in any of them. The inclusion of I-FISH during follow-up of MDS resulted in a small improvement in abnormality detection when compared with conventional G-banding.

Entities:  

Mesh:

Year:  2009        PMID: 19855907     DOI: 10.1590/S0100-879X2009001100018

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  6 in total

1.  Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH: results from a German diagnostic study in comparison with an international control group.

Authors:  Friederike Braulke; Uwe Platzbecker; Catharina Müller-Thomas; Katharina Götze; Ulrich Germing; Tim H Brümmendorf; Florian Nolte; Wolf-Karsten Hofmann; Aristoteles A N Giagounidis; Michael Lübbert; Peter L Greenberg; John M Bennett; Francesc Solé; Mar Mallo; Marilyn L Slovak; Kazuma Ohyashiki; Michelle M Le Beau; Heinz Tüchler; Michael Pfeilstöcker; Thomas Nösslinger; Barbara Hildebrandt; Katayoon Shirneshan; Carlo Aul; Reinhard Stauder; Wolfgang R Sperr; Peter Valent; Christa Fonatsch; Lorenz Trümper; Detlef Haase; Julie Schanz
Journal:  Haematologica       Date:  2014-10-24       Impact factor: 9.941

2.  ERVs-TLR3-IRF axis is linked to myelodysplastic syndrome pathogenesis.

Authors:  Roberta Taiane Germano de Oliveira; João Victor Alves Cordeiro; Bruna Ferreira Vitoriano; Mayara Magna de Lima Melo; Letícia Rodrigues Sampaio; Daniela de Paula Borges; Silvia Maria Meira Magalhães; Ronald Feitosa Pinheiro
Journal:  Med Oncol       Date:  2021-02-17       Impact factor: 3.064

3.  Global Proteomics Analysis of Bone Marrow: Establishing Talin-1 and Centrosomal Protein of 55 kDa as Potential Molecular Signatures for Myelodysplastic Syndromes.

Authors:  Arlindo A Moura; Maria Julia B Bezerra; Aline M A Martins; Daniela P Borges; Roberta T G Oliveira; Raphaela M Oliveira; Kaio M Farias; Arabela G Viana; Guilherme G C Carvalho; Carlos R K Paier; Marcelo V Sousa; Wagner Fontes; Carlos A O Ricart; Maria Elisabete A Moraes; Silvia M M Magalhães; Cristiana L M Furtado; Manoel O Moraes-Filho; Claudia Pessoa; Ronald F Pinheiro
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738

4.  Can synthetic lethality approach be used with DNA repair genes for primary and secondary MDS?

Authors:  Howard Lopes Ribeiro Junior; Roberta Taiane Germano de Oliveira; Daniela de Paula Borges; Marília Braga Costa; Izabelle Rocha Farias; Antônio Wesley Araújo Dos Santos; Silvia Maria Meira Magalhães; Ronald Feitosa Pinheiro
Journal:  Med Oncol       Date:  2019-10-30       Impact factor: 3.064

5.  Identifying the similarities and differences between single nucleotide polymorphism array (SNPa) analysis and karyotyping in acute myeloid leukemia and myelodysplastic syndromes.

Authors:  Thiago Rodrigo de Noronha; Sandra Serson Rohr; Maria de Lourdes Lopes Ferrari Chauffaille
Journal:  Rev Bras Hematol Hemoter       Date:  2014-11-21

6.  Guidelines on myelodysplastic syndromes: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular.

Authors:  Silvia Maria Meira Magalhães; Lígia Niero-Melo; Maria de Lourdes Lopes Ferrari Chauffaille; Elvira Deolinda Rodrigues Pereira Velloso; Irene Lorand-Metze; Renata Buzzini; Wanderley Marques Bernardo
Journal:  Hematol Transfus Cell Ther       Date:  2018-07-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.